1. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.
    Chao Xie et al, 2016, Sci Rep CrossRef
  2. Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages
    Taku Fujimura et al, 2017, Exp Dermatol CrossRef
  3. Imaging Biomarkers in Immunotherapy
    Rosalyn A. Juergens et al, 2016, Biomarkers in Cancer CrossRef
  4. B7-H3 is related to tumor progression in ovarian cancer
    Jingjing Zhang et al, 2017 CrossRef
  5. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
    Zhiliang Wang et al, 2018, Cancer Sci CrossRef
  6. Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration
    Dan Yu et al, 2018, Pathol. Oncol. Res. CrossRef
  7. CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells
    YeonSung Son et al, 2018, Stem Cells CrossRef
  8. The influence of microenvironment on tumor immunotherapy.
    Jieying Zhang et al, 2019, FEBS J CrossRef
  9. Tumor-associated macrophages in cancers
    W. Hu et al, 2016, Clin Transl Oncol CrossRef
  10. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma
    Ling Wang et al, 2016, Tumor Biol. CrossRef
  11. New checkpoints in cancer immunotherapy
    Ling Ni et al, 2017, Immunol Rev CrossRef
  12. LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma
    Yin Gao et al, 2020, Molecular Immunology CrossRef
  13. Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer
    Xin-Jun Cai et al, 2017, Oncotarget CrossRef
  14. Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells
    Weina Zhang et al, 2016, Oncotarget CrossRef
  15. High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder
    Zhili Xu et al, 2018, Oncol Lett CrossRef
  16. B7-H3 Immune Checkpoint Protein in Human Cancer
    Karine Flem-Karlsen et al, 2020, CMC CrossRef
  17. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Zhe Ge et al, 2020, Front Oncol CrossRef
  18. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
    Sangbin Lim et al, 2016, Cancer Res CrossRef
  19. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Yu Jiang et al, 2021, J Exp Clin Cancer Res CrossRef
  20. Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
    Jenny Mattsson et al, 2021, Nat Commun CrossRef
  21. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy
    Marwa Ahmed Sakr et al, 2021, Egypt Liver Journal CrossRef
  22. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
    Dong-Jun Park et al, 2021, IJMS CrossRef
  23. Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
    Alessandro Granito et al, 2021, JHC CrossRef
  24. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy
    Jin Wang et al, 2021, Mol Biotechnol CrossRef
  25. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
    Sibel Durlanik et al, 2021, Sci Rep CrossRef
  26. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
    Guoying Zhou et al, 2021, Br J Cancer CrossRef
  27. Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion
    Roxane R. Lavoie et al, 2021, Cancers CrossRef
  28. The role of B7-H3 in tumors and its potential in clinical application
    Ranran Feng et al, 2021, International Immunopharmacology CrossRef
  29. B7-H3 Suppresses Antitumor Immunity via the CCL2–CCR2–M2 Macrophage Axis and Contributes to Ovarian Cancer Progression
    Taito Miyamoto et al, 2022, Cancer Immunol Res CrossRef
  30. Elucidating Spatially-Resolved Changes in Host Signaling During Plasmodium Liver-Stage Infection
    Elizabeth K. K. Glennon et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
  31. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer
    Kenneth Peuker et al, 2022, Immunity CrossRef
  32. Immune regulation of canine tumour and macrophage PD‐L1 expression
    G. Hartley et al, 2017, Vet Comparative Oncology CrossRef
  33. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
    Binghao Zhao et al, 2022, J Hematol Oncol CrossRef
  34. Dectin3 protects against hepatocellular carcinoma by regulating glycolysis of macrophages
    Wei Qu et al, 2022, International Immunopharmacology CrossRef
  35. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer
    Li-ting Wang et al, 2022, Front. Oncol. CrossRef
  36. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
    Songxin Zhu et al, 2022, Front. Immunol. CrossRef
  37. Inhibition of the B7-H3 immune checkpoint limits hepatocellular carcinoma progression by enhancing T lymphocyte-mediated immune cytotoxicity in vitro and in vivo
    Zixiong Zhou et al, 2022, Clin Transl Oncol CrossRef
  38. CD203c is expressed by human fetal hepatoblasts and distinguishes subsets of hepatoblastoma
    Marcus O. Muench et al, 2023, Front. Oncol. CrossRef
  39. Targeting B7-H3—A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment
    Petar Rasic et al, 2023, Molecules CrossRef
  40. Macrophage CD5L is a target for cancer immunotherapy
    Lidia Sanchez-Moral et al, 2023, eBioMedicine CrossRef
  41. B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours
    Sylwia Mielcarska et al, 2023, Cancers CrossRef
  42. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy
    Siji Chen et al, 2023, J Cancer Res Clin Oncol CrossRef
  43. The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
    Xinyi Zhang et al, 2023, Cancer Medicine CrossRef
  44. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
    Ioannis-Alexios Koumprentziotis et al, 2024, Vaccines CrossRef
  45. High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis
    Dongze Zhang et al, 2024, Translational Oncology CrossRef
  46. The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages
    Robin Park et al, 2024, Immunol Res CrossRef
  47. Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis
    Haohao sun et al, 2024, BMC Urol CrossRef
  48. CAR T Cells redirected to B7-H3 for pediatric Solid Tumors: Current Status and Future Perspectives
    Rebecca Epperly et al, 2024, EJC Paediatric Oncology CrossRef
  49. Photo‐metallo‐immunotherapy: Fabricating Chromium‐Based Nanocomposites to Enhance CAR‐T Cell Infiltration and Cytotoxicity against Solid Tumors
    Qingshuang Zou et al, 2024, Advanced Materials CrossRef
  50. Relationship between EZH2 expression and prognosis of patients with hepatocellular carcinoma using a pathomics predictive model
    Xulin Zhou et al, 2024, Heliyon CrossRef
  51. Experience with regorafenib in the treatment of hepatocellular carcinoma
    Alessandro Granito et al, 2021, Therap Adv Gastroenterol CrossRef
  52. Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC
    Muhammad Naveed Khan et al, 2024, Front. Immunol. CrossRef